Page 13 - Rhizen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Google I/O is an annual developer conference where the technology giant showcases its innovation competence with regard to products and services. This year, the company showcased some futuristic technologies besides detailing the upgrades coming to Android and Wear OS operating systems for smartphones and smartwatches, respectively. The Google I/O 2021 was full of surprises and interesting announcements. Here is a quick recap of everything announced at the Google I/O 2021: Google has come a long way enhancing its Android operating system for smartphones. The next iteration of the OS is set t...

18 May 2021, 09:05 pm Google and Samsung are joining forces to combine the best features of Wear OS of Android and Tizen, the operating system of Galaxy wearables. The launched alliance will give birth to what will be called "Wear." -- perhaps to better compete with the reigning watchOS of Apple. The new name may have been reduced, but the upcoming features will be more, according to Google. This time around, as it may seem, Google is taking wearables seriously. (Photo : Justin Sullivan/Getty Images) MOUNTAIN VIEW, CA - MAY 08: Android smart watches are displayed at the Google I/O 2018 Con...

| 19 February 2021 Building on the traction it has gained from recent high-profile drama commissions, producer-led content group iZen, comprising independent production companies in Spain, the Middle East and the UK, has announced its latest scripted project for the global market. The company has optioned La Ciudad de los Prodigios (City of Marvels) and is now in development on a six-part series based on Eduardo Mendoza’s acclaimed Spanish historical novel. Published in 1986 and translated into 14 languages, City of Marvels chronicles Onofre Bouvila’s journey from small-time ...

(1) Umbralisib (UKONIQ) granted accelerated approval by US FDA for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL), follicular lymphoma (FL). Umbralisib, a novel next generation inhibitor of PI3K delta CK1 epsilon, was discovered by Rhizen Pharmaceuticals and subsequently licensed to TG Therapeutics, who led the asset's clinical development. Rhizen and its affiliate Alembic Pharma to support TG Therapeutics towards UKONIQ's commercialization as its manufacturing supply partner; Rhizen plans to register and commercialize Umbralisib in India. Rhizen Phar...

BBC/SundanceTV's 'The Split' to Call It Quits After Season Three - Global Bulletin Jamie Lang, provided by FacebookTwitterEmail In today’s Global Bulletin, BBC and SundanceTV announce the third and final season of “The Split,” Sky and XYZ Films prepare to shoot “Book of Love” and VIS Distribution adds 750 hours of content following its acquisition of Israel’s Ananey Studios.  TELEVISION Sister’s “ Abi Morgan and produced by Jane Featherstone (“Chernobyl”), Lucy Richer (“Small Axe”), with Dee Koppang O’Leary (“Bridgerton,” “The Crown”) boarding as lead di...